JETIREXPLORE- Search Thousands of research papers



Published in:

Volume 5 Issue 12
December-2018
eISSN: 2349-5162

Unique Identifier

JETIRDZ06111

Page Number

848-856

Share This Article


Title

Psoriasis scoring and its outcome on the quality of human life: An updated review

ISSN

2349-5162

Cite This Article

"Psoriasis scoring and its outcome on the quality of human life: An updated review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 12, page no.848-856, December 2018, Available :http://www.jetir.org/papers/JETIRDZ06111.pdf

Abstract

Psoriasis is a chronic skin condition with the presence of abundant T lymphocyte. Mostly affected at the age of 20 or 50 years and is associated with co-morbidities like cardiovascular risk factors, diabetics mellitus, inflammatory bowel disease (IBD), obesity, metabolic syndromes, non-melanoma, and its skin cancer. Psoriasis patients suffer from the physical, psychological, emotional, social and economic burden and are challenging to their health-related quality of life. Disease severity is measured with the assistance of numerous scoring such as i) Psoriasis Area Severity Index (PASI), ii) Physician Global Assessment (PGA) and iii) Body Surface Area (BSA) while the quality of life impairment of patient is measured with various indexes such as i) Dermatology Life Quality Index (DLQI), ii) Feelings of Stigmatization Questionnaire (FSQ), iii) Short form 36 (SF 36), and iv) Human Anxiety and Depression Scale (HADS). Usage of these screening tools concludes how the severity of the disease affects the patient’s day to day activities and their quality of life. The primary intention for psoriasis treatment is to scale down the severity of disease condition as well as improve the quality of life. The proper choice of drug therapy for the identified disease with patient compliance can improve the status of patient life. The present manuscript covers literature related to the demographic characteristics, psychological status, disease severity, and its co-morbidities, medication effect and economic burden on Human Related Quality of Life (HRQoL). On account of the collected data better treatment can be suggested and the psychological burden on their life can be reduced.

Key Words

Psoriasis, quality of life, severity score, clinical, skin, dermal.

Cite This Article

"Psoriasis scoring and its outcome on the quality of human life: An updated review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp848-856, December 2018, Available at : http://www.jetir.org/papers/JETIRDZ06111.pdf

Publication Details

Published Paper ID: JETIRDZ06111
Registration ID: 233738
Published In: Volume 5 | Issue 12 | Year December-2018
DOI (Digital Object Identifier):
Page No: 848-856
ISSN Number: 2349-5162

Download Paper

Preview Article

Download Paper




Cite This Article

"Psoriasis scoring and its outcome on the quality of human life: An updated review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp848-856, December 2018, Available at : http://www.jetir.org/papers/JETIRDZ06111.pdf




Preview This Article


Downlaod

Click here for Article Preview